K-BIOA LEADER IN ACTIVE IMMUNE CANCER THERAPY and after-care with the AUTOLOGOUS - won out of patients own blood - HUMANE IMMUNE-MEDIATORS
/ CYTOKINES and related EFFECTORS AHICE. We about us We are a team of specialized scientists - biochemists, immunologists, clinical chemists, physicians, biologists - and technical assistants, coming from biochemical and
medical-diagnostical laboratory-field.We developed over a long term of biochemical/immunological studies the active immunological, tumourcell specific cancer-therapy AHICET "Autologous Human Immune-mediators / Cytokines and related Effectors"(patent pending). This "Autologous Human Immune-mediators / Cytokines and related Effectors Tumourtherapy AHICET"
is distinguished by:
highly specific directed against tumourcells and therefore purposeful active immunological tumourtherapy with highest intelligent antigen-detection-ability - attacks not only on the tumourside, but also on
the metastaticsites.remarkable high effectivity in relation to the poor results of the conservative tumourtherapy. as the AHICE are atologous produced, there are none
secondary effects possible and not known. it is significant increasing of patients live-quality.
Our active immunological tumourtherapy AHICET can
combined with the stationary applied Proton-Radiation-therapy. This application can be more efficient in cases of solid inoperable primary tumours. Home
<= back...
next... => products |